Although CBD oils aren’t regulated by the FDA, purchasing products stateside from one of the nine states where recreational and medical cannabis use is legal will likely result in a higher-quality product than buying one made with hemp-derived CBD oil imported from abroad, says Martin Lee, director of Project CBD, a nonprofit that promotes medical research into CBD.
Buying online is less reliable still because there’s no regulation or standardization. What you see on the label may not be what you are getting. A 2017 study in JAMA found that of the 84 CBD products researchers bought online, 43% had more CBD than indicated, while 26% had less, and some had unexpected THC. “There’s a 75% chance of getting a product where the CBD is mislabeled,” says Marcu, one of the study’s coauthors.
The endocannabinoid system is tonically active in control of pain, as demonstrated by the ability of SR141716A (rimonabant), a CB1 antagonist, to produce hyperalgesia upon administration to mice (Richardson et al 1997). As mentioned above, the ECS is active throughout the neuraxis, including integrative functions in the periacqueductal gray (Walker et al 1999a; Walker et al 1999b), and in the ventroposterolateral nucleus of the thalamus, in which cannabinoids proved to be 10-fold more potent than morphine in wide dynamic range neurons mediating pain (Martin et al 1996). The ECS also mediates central stress-induced analgesia (Hohmann et al 2005), and is active in nociceptive spinal areas (Hohmann et al 1995; Richardson et al 1998a) including mechanisms of wind-up (Strangman and Walker 1999) and N-methyl-D-aspartate (NMDA) receptors (Richardson et al 1998b). It was recently demonstrated that cannabinoid agonists suppress the maintenance of vincristine-induced allodynia through activation of CB1 and CB2 receptors in the spinal cord (Rahn et al 2007). The ECS is also active peripherally (Richardson et al 1998c) where CB1 stimulation reduces pain, inflammation and hyperalgesia. These mechanisms were also proven to include mediation of contact dermatitis via CB1 and CB2 with benefits of THC noted systemically and locally on inflammation and itch (Karsak et al 2007). Recent experiments in mice have even suggested the paramount importance of peripheral over central CB1 receptors in nociception of pain (Agarwal et al 2007)
What makes these plants of interest to scientists, healers, and those in need of treatment is cannabidiol, or CBD. CBD is present in both hemp and marijuana, but what makes marijuana psychoactive — giving you the ‘high’ sensation — is tetrahydrocannabinol (THC). Hemp contains only trace amounts of THC, and studies have shown that CBD is not psychoactive like THC.
Ananda Hemp is a tempting brand to say the least. They source their seeds from the largest hemp seed bank in the United States and have generational farmers grow their products. Plus, they offer excellent customer service with their products. However, I was disappointed that they had only two concentrations of tinctures available, one amounting to 200 mg and other being 600 mg.
Why support the endocannabinoid system? The endocannabinoid system (ECS) is gaining attention in the public eye for its role in contributing to an individual’s overall health and well-being by supporting the body’s physiological homeostasis. The ECS regulates nearly every metabolic process in the body system. A well-balanced ECS encourages favorable conditions in the body system, impacting the body’s ability to manage metabolic stress1 and may support overall health and well-being.2